Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Nicoll

Showing results (91-100 of 147) with videos related to

Pageof 15
Sort By:
Acta Neuropathologica Communications|November 21, 2013
Immune complex formation impairs the elimination of solutes from the brain: implications for immunotherapy in Alzheimer's diseaseRoxana Octavia Carare, Jessica Liesbeth Teeling, Cheryl A Hawkes, et al.
Scientific Reports|May 16, 2015
Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia Caused by a Novel R782G Mutation in CSF1RNicola Foulds, Reuben J Pengelly, Simon R Hammans, et al.
Neuropathology and Applied Neurobiology|December 10, 2014
Effect of amyloid-β (Aβ) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK)-3βJay Amin, Claire Paquet, Alex Baker, et al.
Journal of the International Neuropsychological Society : JINS|December 20, 2013
"Forgetting to remember" in Huntington's disease: a study of laboratory, semi-naturalistic, and self-perceptions of prospective memoryDiane R Nicoll, Eva Pirogovsky, Steven Paul Woods, et al.
Neuropathology and Applied Neurobiology|January 23, 2008
Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunologyR O Carare, M Bernardes-Silva, T A Newman, et al.
The Lancet. Neurology|September 20, 2024
Brain volume change following anti-amyloid β immunotherapy for Alzheimer's disease: amyloid-removal-related pseudo-atrophyChristopher R S Belder, Delphine Boche, James A R Nicoll, et al.
Neuropathology and Applied Neurobiology|December 13, 2012
The neuroinflammatory response in humans after traumatic brain injuryC Smith, S M Gentleman, P D Leclercq, et al.
Journal of Neuroinflammation|June 4, 2016
Microglial immunophenotype in dementia with Alzheimer's pathologyThais Minett, John Classey, Fiona E Matthews, et al.
Alzheimer'S Research & Therapy|December 1, 2020
Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapyJacqui T Nimmo, Ajay Verma, Jean-Cosme Dodart, et al.
Clinical Neuropathology|December 5, 2006
No evidence for the presence of apolipoprotein epsilon4, interleukin-lalpha allele 2 and interleukin-1beta allele 2 cause an increase in programmed cell death following traumatic brain injury in humansV E Johnson, L Murray, R Raghupathi, et al.
Pageof 15

Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
Acta Neuropathologica Communications|November 21, 2013
Immune complex formation impairs the elimination of solutes from the brain: implications for immunotherapy in Alzheimer's diseaseRoxana Octavia Carare, Jessica Liesbeth Teeling, Cheryl A Hawkes, et al.
Scientific Reports|May 16, 2015
Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia Caused by a Novel R782G Mutation in CSF1RNicola Foulds, Reuben J Pengelly, Simon R Hammans, et al.
Neuropathology and Applied Neurobiology|December 10, 2014
Effect of amyloid-β (Aβ) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK)-3βJay Amin, Claire Paquet, Alex Baker, et al.
Journal of the International Neuropsychological Society : JINS|December 20, 2013
"Forgetting to remember" in Huntington's disease: a study of laboratory, semi-naturalistic, and self-perceptions of prospective memoryDiane R Nicoll, Eva Pirogovsky, Steven Paul Woods, et al.
Neuropathology and Applied Neurobiology|January 23, 2008
Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunologyR O Carare, M Bernardes-Silva, T A Newman, et al.
The Lancet. Neurology|September 20, 2024
Brain volume change following anti-amyloid β immunotherapy for Alzheimer's disease: amyloid-removal-related pseudo-atrophyChristopher R S Belder, Delphine Boche, James A R Nicoll, et al.
Neuropathology and Applied Neurobiology|December 13, 2012
The neuroinflammatory response in humans after traumatic brain injuryC Smith, S M Gentleman, P D Leclercq, et al.
Journal of Neuroinflammation|June 4, 2016
Microglial immunophenotype in dementia with Alzheimer's pathologyThais Minett, John Classey, Fiona E Matthews, et al.
Alzheimer'S Research & Therapy|December 1, 2020
Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapyJacqui T Nimmo, Ajay Verma, Jean-Cosme Dodart, et al.
Clinical Neuropathology|December 5, 2006
No evidence for the presence of apolipoprotein epsilon4, interleukin-lalpha allele 2 and interleukin-1beta allele 2 cause an increase in programmed cell death following traumatic brain injury in humansV E Johnson, L Murray, R Raghupathi, et al.
Pageof 15